The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants

MEDICAL EXECUTIVE-POST – TODAY’S NEWSLETTER BRIEFING

***

Essays, Opinions and Curated News in Health Economics, Investing, Business, Management and Financial Planning for Physician Entrepreneurs and their Savvy Advisors and Consultants

“Serving Almost One Million Doctors, Financial Advisors and Medical Management Consultants Daily“

A Partner of the Institute of Medical Business Advisors , Inc.

http://www.MedicalBusinessAdvisors.com

SPONSORED BY: Marcinko & Associates, Inc.

***

http://www.MarcinkoAssociates.com

REFER A COLLEAGUE: MarcinkoAdvisors@out.com

SPONSORSHIPS AVAILABLE: https://medicalexecutivepost.com/sponsors/

ADVERTISE ON THE ME-P: https://tinyurl.com/ytb5955z

Your Referral Count -0-

***

CITE: https://www.r2library.com/Resource

The FTC’s second interim staff report on consolidated pharmacy benefit managers (PBMs) found that the three largest of these middlemen—CVS Health’s Caremark Rx, Cigna Group’s Express Scripts, and UnitedHealth Group’s OptumRx—”marked up two specialty generic cancer drugs by thousands of percent and then paid their affiliated pharmacies hundreds of millions of dollars of dispensing revenue in excess of estimated acquisition costs for each drug annually.”

CITE: https://tinyurl.com/2h47urt5

🟢 What’s up

• Crypto stocks climbed after the Senate passed the GENIUS Act, a bill that ushers in a new era of stablecoin acceptance. Coinbase rose 16.32%, Circle added 33.82%, and JPMorgan, which is rolling out its own stablecoin, climbed 1.65%.
• SunRun recovered 6.06% following the solar stock’s biggest one-day loss in company history.
• Oracle rose 1.29% after Guggenheim analysts raised their price target for the software stock, noting that its revenue could accelerate in the coming years.
• TKO Group popped 4.75% on back-to-back upgrades from Citi and Bernstein analysts, who think the UFC and WWE parent company will profit nicely from its broadcasting rights.
• Scholar Rock Holding added 16.60% after the biotech announced its latest drug can help patients taking Eli Lilly’s weight-loss drugs lose less muscle as they shed weight.

What’s down

• CERo Therapeutics plunged 42.01% a day after the immunotherapy company soared after its acute myeloid leukemia treatment received an orphan drug designation from the FDA.
• Credit card companies tumbled on fears that stablecoins will disrupt the payment industry. Mastercard fell 5.39%, and Visa sank 4.88%.
• Zoetis lost 4.03% thanks to a downgrade from Stifel analysts, who think competition will eat into the animal medication and vaccine market.
• Allstate fell 1.27% after the insurer reported $777 million in catastrophic losses last month.

CITE: https://tinyurl.com/tj8smmes

Stat: 600. That’s how many employees Washington-based nonprofit health system Providence is laying off across seven states. (Fierce Healthcare)

Quote: “If we can make one thing a little bit easier for a lot of people, we’ll save them a lot of time, a lot of money, and some lives.”—Neil Lindsay, SVP of Amazon Health Services, on Amazon’s recent healthcare business reorganization (CNBC)

Read: A second Duchenne muscular dystrophy patient has died after using Sarepta Therapeutics’s gene therapy treatment Elevidys. (Biopharma Dive)

Investments are soaring: A new SVB report found that women’s health startups saw a whopping 55% increase in VC investments in 2024. Learn about the factors driving this record-breaking funding and the sector’s long-term potential.*

Visualize: How private equity tangled banks in a web of debt, from the Financial Times.

COMMENTS APPRECIATED

PLEASE SUBSCRIBE: MarcinkoAdvisors@outlook.com

Thank You

***

***

***

***

EDUCATIONAL TEXTBOOKS: https://tinyurl.com/4zdxuuwf

***

Filed under: Drugs and Pharma, Ethics, Information Technology, Investing, Marcinko Associates, Recommended Books, Sponsors | Tagged: DJIA, DOW, Drugs, Marcinko, NASA, NASDAQ, PBMs, S&P 500, textbooks, WSJ |